Parataxis Holdings has invested $183.3 million in Bridge Biotherapeutics to establish South Korea’s first Bitcoin-native treasury platform. The deal transforms the publicly traded biotech firm into a corporate Bitcoin vehicle, capitalizing on growing institutional interest in cryptocurrency reserves. This strategic acquisition follows similar Bitcoin treasury initiatives by companies like MicroStrategy and Metaplanet.
The $183.3 million investment gives Parataxis controlling interest in Bridge Biotherapeutics, which will be renamed Parataxis Korea. The Seoul-based company will shift from biotech development to focus exclusively on Bitcoin treasury management while remaining listed on the KOSDAQ exchange. Edward Chin, Founder of Parataxis Holdings, will join the board alongside new CEO Andrew Kim.
“We’re creating South Korea’s first BTC treasury company backed by institutional-grade infrastructure,” stated Chin. The platform aims to provide disciplined Bitcoin accumulation strategies for shareholders, citing Bitcoin’s finite supply as a long-term value proposition. This move comes amid South Korea’s gradual opening of institutional crypto access through its real-name account pilot program.
Get breakout alerts
Install Coin Push to get profitable crypto trading notifications.
Parataxis: Institutional Gateway to Bitcoin
The New York-based investment firm specializes in digital asset strategies, having recently announced plans for a $200 million public listing via special acquisition company. Parataxis Capital partner Andrew Kim emphasized the platform’s focus on “sound corporate governance and disciplined capital management” for Bitcoin exposure. The firm selected South Korea due to its progressive regulatory developments and growing institutional demand.
Parataxis Korea will leverage its parent company’s expertise in cryptocurrency investments while complying with South Korea’s Financial Services Commission guidelines. The treasury platform launches as South Korea permits 3,500 corporations to open crypto trading accounts through its ongoing pilot initiative. This institutional framework positions Parataxis at the forefront of regulated Bitcoin adoption in Asia.
Bridge Biotherapeutics: Strategic Pivot
The Seongnam-based biotech company experienced a 20% stock surge following the acquisition announcement. Bridge Biotherapeutics co-founder James Jungkue Lee will continue leading the core biotech operations while serving on the board of the transformed entity. The company’s existing therapeutic research programs will continue under the restructured organization.
Bridge Bio’s public listing on the KOSDAQ provides the ideal vehicle for Parataxis’s Bitcoin treasury ambitions. The transaction requires shareholder approval, with a vote scheduled for August 2025. Upon closing, the company will immediately begin reallocating capital toward Bitcoin acquisition as part of its new treasury mandate.
Corporate Bitcoin Adoption Accelerates
The Parataxis Korea initiative mirrors corporate Bitcoin strategies gaining global traction. Over 237 public companies now hold Bitcoin reserves, more than doubling from 124 companies just weeks earlier. These corporate holdings represent approximately 3.96% of Bitcoin’s total supply according to industry trackers.
| Metric | Value |
|---|---|
| Public Companies Holding BTC | 237 |
| Previous Count (May 2025) | 124 |
| Total BTC Supply Held | 3.96% |
South Korea’s evolving regulatory landscape enables this development, despite current bans on Bitcoin ETFs and institutional crypto funds. The Financial Services Commission’s real-name account program represents a phased approach to institutional crypto access. Parataxis Korea will serve as a test case for corporate Bitcoin adoption in Asia’s fourth-largest economy.
The treasury model follows successful precedents like Japan’s Metaplanet, which has seen significant valuation increases following Bitcoin acquisitions. Parataxis explicitly cited these cases as inspiration for their South Korean venture. This trend reflects growing corporate confidence in Bitcoin as a treasury reserve asset despite market volatility.
Corporate Bitcoin adoption continues expanding beyond technology firms into diverse sectors including biotech, finance, and healthcare. The strategy typically involves allocating portions of cash reserves to Bitcoin as a hedge against currency devaluation. Parataxis Korea represents the first dedicated Bitcoin treasury vehicle in South Korea’s public markets.
Market analysts view this development as a significant milestone for cryptocurrency institutionalization in Asia. The Parataxis model could inspire similar ventures across the region if successful. South Korea’s advanced digital infrastructure and high crypto adoption rate provide an ideal testing ground for institutional Bitcoin products.
Install Coin Push mobile app to get profitable crypto alerts. Coin Push sends timely notifications – so you don’t miss any major market movements.
This acquisition signals deepening institutional commitment to Bitcoin as corporations increasingly view cryptocurrency as a legitimate treasury asset. The Parataxis Korea model may accelerate regulatory acceptance and inspire similar corporate Bitcoin strategies across Asia. As more public companies allocate reserves to cryptocurrency, Bitcoin’s role in corporate finance continues evolving from speculative asset to balance sheet staple.
- Bitcoin (BTC)
- A decentralized digital currency operating without central authority, secured by blockchain technology and limited to 21 million coins.
- Treasury Platform
- A corporate structure designed to acquire and hold reserve assets like Bitcoin on a company’s balance sheet.
- KOSDAQ
- South Korea’s stock market for small and medium-sized companies, similar to the NASDAQ in the United States.
- Special Acquisition Company
- A blank-check company formed to raise capital through IPO for acquiring existing businesses.
